Weightloss drug to be pulled from market after FDA expresses concerns on cancer risk

Weight-loss drug to be pulled from market after FDA expresses concerns on cancer risk

The Japanese drug maker Eisai said it would withdraw the weight-loss drug Belviq from the U.S. market after the FDA expressed concerns about an increased occurrence of cancer reported in…

More From BioPortfolio on "Weight-loss drug to be pulled from market after FDA expresses concerns on cancer risk"